Skip to search formSkip to main contentSkip to account menu

MicroRNA 29b

Known as: has-mir-29b, MIR29B, MIRN29b 
A 23 ribonucleotide sequence that is a final product of the processing of either MIR29B1 pre-miRNA or MIR29B2 pre-miRNA. This oligonucleotide may be… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Abstract Lesson Learned. Circulating tumor cells, microRNA markers, or other biomarkers merit examination as part of correlative… 
2016
2016
Peptides have been in the limelight, as therapeutic agents for cancer treatment through various applications due to their high… 
2016
2016
Peptides have been in the limelight, as therapeutic agents for cancer treatment through various applications due to their high… 
2016
2016
BACKGROUND In lung cancer, miR-29b can act as a tumor suppressor, influencing epigenetic regulation, cell proliferation… 
2015
2015
PurposeRecent studies have suggested that microRNA-29 (miR-29) family members may play important roles in human cancer by… 
2015
2015
Background and Objective : Various cellular factors affect the process of HIV activity. One of these cellular factors are… 
2015
2015
The presence of a small number of infected but transcriptionally dormant cells currently thwarts a cure for the more than 35… 
2013
2013
Multiple myeloma (MM) is a heterogeneous disease originating from the transformation of a post-germinal center B cell. MM… 
2013
2013
Breast cancer patients with metastatic disease have poor prognoses. A key transcription factor, the loss of GATA3 by mutation or… 
2011
2011
MLLT11, an MLL fusion partner, is a poor prognostic biomarker for paediatric acute myeloid leukaemia (AML), adult normal…